ArticlePregnancy (Hoboken, N.J.)2026
Postpartum blood pressure trends and time in target range during remote blood pressure monitoring.
Article in Pregnancy (Hoboken, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Introduction: Postpartum remote blood pressure monitoring (RBPM) programs have emerged as an important adjunct to the management of hypertensive disorders of pregnancy (HDP). These programs have demonstrated robust patient participation and satisfaction with reduced readmissions and severe maternal morbidity. Despite this, data describing blood pressure (BP) trends throughout program participation and across different antihypertensive regimens remain limited. We sought to evaluate BP trends and time in target range (TTR) during our 6-week RBPM program. Methods: This is a retrospective cohort study of postpartum individuals participating in an RBPM program from November 2023 through December 2024. This program utilizes a standardized nurse (RN)-driven protocol for antihypertensive medication initiation and titration to achieve a goal BP of <140/90 mmHg. Target range was defined as SBP (systolic BP) 100-139 mmHg and DBP (diastolic BP) 60-89 mmHg. The primary outcomes were BP trend and TTR throughout program participation stratified by antihypertensive medication at discharge. Results: The cohort included 465 individuals. Mean BPs were <140/90 mmHg for all groups for each program week. Most participants were within the target range throughout with TTR between 80.3% and 90.4%. Of participants, 175 (81.4%) were prescribed nifedipine monotherapy and 40 (18.6%) labetalol monotherapy. Mean BP trends were within goal for both groups; however, those discharged with nifedipine spent more TTR (nifedipine 87.5% vs. labetalol 80.3%, Conclusion: Postpartum RBPM is an important tool for postpartum care. Utilization of a standardized RN-driven protocol for antihypertensive medication initiation and titration can result in optimal BP management irrespective of medication regimen at discharge. These data suggest that nifedipine may be associated with more rapid and sustained achievement of target BPs throughout 6 weeks postpartum compared to labetalol.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.